Pharmafile Logo

Lucid Group are shortlisted in three different categories at this year’s PMEA programme

October 16, 2018 |  

- PMLiVE

Lucid’s talent for working together with their clients to create magical programmes is clear to see as they celebrate three of their campaigns making the 2018 PMEA finals, well as making the cut for PMEA Support Agency of Year.

Jan Steele, Lucid Group COO and Co-founder commented, “We are extremely proud of our client partnerships. By continuing to push boundaries and creating industry-leading medical communications, we have, together, been able to transform the lives of those we touch. I am thrilled that their work has been shortlisted at this year’s PMEA.”

The PMEA programme aims to recognise work that delivers clearly identifiable benefits and improved outcomes for patients. The winners will be announced at the awards ceremony on Thursday 22nd November at The Tower – A Guoman Hotel.

More details about the shortlisted campaigns can be found below:

Excellence in Rare Diseases and Orphan Drugs:            

  • Revolutionising management of hidradenitis suppurativa in Europe: Why? What? How?
  • Advancing Science in a Rare Disease – A Cost Effective Clinical Decision Support Programme for Cystinosis.

Excellence in Healthcare Professional Education and Support Programmes:    

  • OptiMiSe: Delivering patient-centric management in MS through clinical behaviour change.

PMEA Support Agency of the Year:

  • LUCID : THE TRANSFORMATION

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.